July 18, 2019 - FDA Approves New Brain Tumor Trial – and more news

Published:
 
 
July 18, 2019
FDA Approves New Focused Ultrasound Trial to Treat Deadly Brain Tumors

French manufacturer, CarThera, recently announced that the US Food & Drug Administration (FDA) has granted approval to begin a US clinical trial of their SonoCloud-9 ultrasound device in patients with recurrent glioblastoma (GBM).

READ MORE >
 Foundation News
Blog: Foundation Chairman on the Future of Focused Ultrasound

Foundation Chairman Neal Kassell, MD, predicts that collaboration, commercialization, and competition are the keys to driving the field forward.

READ THE BLOG POST >


 
Donor Profile: Albert Small, Sr. 

Foundation Research Assistant, Isabella Small, recently spoke with her grandfather, Albert Small, about why he is excited about focused ultrasound’s impact on medicine. 

READ MORE >


Research News
Research Spotlight: New Targets in Treating Essential Tremor

A team in London has developed a new method for treating essential tremor patients involving ablating two areas in the brain. 

READ MORE >

Sunnybrook Awarded $1.4 Million to Treat Essential Tremor Patients

The Toronto site announced the $1.4 million investment will allow them to treat 72 more essential tremor patients.  

READ MORE >


 
Meeting Report: WSSFN 2019

The 18th biennial meeting of the World Society for Stereotactic and Functional Neurosurgery featured a variety of focused ultrasound presentations.

VIEW THE MEETING REPORT >

Research Roundup

A team in Toronto is exploring using an MR imaging technique called tractography to improve treatments in patients with Alzheimer’s disease.
 
READ MORE >

Visit our free, online research library of focused ultrasound publications.
 More Research News
Industry News
Company Profile: FUSMobile

This spring, FUSMobile completed its first clinical trial in Canada using their mobile, user-friendly Neurolyser device.

READ MORE >

VIDEO: FUSMOBILE CO-FOUNDERS DISCUSS DEVICE, TRIAL >
 

Insightec Device Compatible with SIGNA Premier MR System

Insightec’s Exablate Neuro device has earned FDA approval and CE mark to be used with GE Healthcare’s SIGNATM Premier MRI System.  

READ MORE >

FDA Provides Guidance for Prostate Tissue Ablation Devices

The FDA has issued a draft guidance for clinical investigations of prostate tissue ablation devices including focused ultrasound systems. 

READ MORE >

 More Industry News
Do you have news for our newsletter? Tell us about it! 
Upcoming Events
July 23-27, 2019 IEEE 41st International Engineering in Medicine and Biology Conference (EMBC 2019), Berlin, Germany

August 2-6, 2019 American Veterinary Medicine Association (AVMA) Convention, Washington, DC

August 13-15, 2019 B3DD Blood Brain Barrier Drug Delivery Summit, Boston, MA

August 16-17, 2019 Society for NeuroOncology (SNO) Inaugural Conference on Brain Metastases, New York, NY

August 29-31, 2019 5th World Congress on Parkinsons & Huntington Disease, Vienna, Austria 

September 5, 2019 Medical Device Innovation Consortium (MDIC) Annual Public Forum, Washington, DC

September 12-14, 2019 4th International Symposium on Hypothalamic Hamartoma (HOPE), Washington, DC

September 15-18, 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, Chicago, IL

September 16-17, 2019 20th International Conference on Alzheimer's Drug Discovery, Jersey City, NJ

September 22-26, 2019 International Congress of Parkinson's Disease and Movement Disorders, Nice, France

September 23-24, 2019 Focused Ultrasound Neuromodulation Symposium, Oxford, UK  Poster Deadline is September 2, 2019

September 27 – October 1, 2019 European Society for Medical Oncology Congress, Barcelona, Spain